前列腺影像报告和数据系统第2版(PI-RADS v2)的应用:观察者间一致性与对中高级别前列腺癌定位的阳性预测值
回顾性纳入131例连续患者,评估PI-RADS v2在mpMRI上定位中高级别前列腺癌的观察者间一致性与阳性预测值。两位不同经验阅片者间ICC为0.74(全部病灶)、0.72(外周带)、0.67(移行带),PI-RADS 2、3、4、5类的PPV分别约为0%、12%、64%、87%。PI-RADS v2观察者间一致性仅为中等,但各分类PPV在两位阅片者间非常相似,评分与中高级别癌可能性相关性好。
要点
- PI-RADS v2评分与中高级别前列腺癌可能性相关性好,PI-RADS 4类和5类PPV分别约64%和87%。
- 两位不同经验阅片者间观察者间一致性为中等,全部病灶ICC为0.74。
- 尽管一致性仅中等,两位阅片者各PI-RADS分类的PPV非常相似。
核心结论
- PI-RADS v2观察者间一致性仅为中等,与原始PI-RADS及PI-RADS v2初始研究结果相似;但PI-RADS v2似乎是有用的预测显著前列腺癌的系统,PI-RADS评分与中高级别癌可能性相关性好。
研究设计与样本
- 回顾性、经机构审查委员会批准的研究,纳入131例连续接受mpMRI后行经直肠超声-MR融合引导前列腺活检的患者;两位对初始mpMRI报告、临床数据和病理结果设盲的阅片者独立阅片、识别所有前列腺病灶并按PI-RADS v2评分;以ICC评估观察者间一致性,计算各PI-RADS分类的PPV。
诊断标准与关键数值
- 两位阅片者间ICC为0.74(全部病灶)、0.72(外周带病灶)、0.67(移行带病灶);检测中高级别前列腺癌的PPV约为0%(PI-RADS 2类)、12%(PI-RADS 3类)、64%(PI-RADS 4类)、87%(PI-RADS 5类)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate interobserver agreement with the use of and the positive predictive value (PPV) of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) for the localization of intermediate- and high-grade prostate cancers on multiparametric magnetic resonance imaging (mpMRI).
MATERIALS AND METHODS: In this retrospective, institutional review board-approved study, 131 consecutive patients who had mpMRI followed by transrectal ultrasound-MR imaging fusion-guided biopsy of the prostate were included. Two readers who were blinded to initial mpMRI reports, clinical data, and pathologic outcomes reviewed the MR images, identified all prostate lesions, and scored each lesion based on the PI-RADS v2. Interobserver agreement was assessed by intraclass correlation coefficient (ICC), and PPV was calculated for each PI-RADS category.
RESULTS: PI-RADS v2 was found to have a moderate level of interobserver agreement between two readers of varying experience, with ICC of 0.74, 0.72, and 0.67 for all lesions, peripheral zone lesions, and transitional zone lesions, respectively. Despite only moderate interobserver agreement, the calculated PPV in the detection of intermediate- and high-grade prostate cancers for each PI-RADS category was very similar between the two readers, with approximate PPV of 0%, 12%, 64%, and 87% for PI-RADS categories 2, 3, 4, and 5, respectively.
CONCLUSIONS: In our study, PI-RADS v2 has only moderate interobserver agreement, a similar finding in studies of the original PI-RADS and in initial studies of PI-RADS v2. Despite this, PI-RADS v2 appears to be a useful system to predict significant prostate cancer, with PI-RADS scores correlating well with the likelihood of intermediate- and high-grade cancers.
引用
- Chen F, Cen S, Palmer S, et al. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging. Acad Radiol. 2017. PMID: 28546032. doi:10.1016/j.acra.2017.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。